Introduction 70
In 2015 there were an estimated 480,000 cases of multidrug-resistant (MDR) 71 tuberculosis (TB) worldwide [1] . MDR TB (resistance to at least isoniazid and rifampin) 72 treatment is less effective, more toxic and costly compared to drug susceptible TB [2] . 73 Importantly MDR TB is associated with poor TB treatment outcomes and increased risk 74 of death [3, 4] , in 2014 there were an estimated 190,000 deaths from MDR TB [5] .
The primary outcome of interest for the study was time to initial sputum culture 140 conversion. Sputum cultures were performed monthly during MDR TB treatment. 141 Mycobacterial cultures and drug-susceptibility testing (DST) were performed as 142 previously described [4] . Time to sputum culture conversion was defined by the number 143 of days between MDR TB treatment initiation and the first of two negative sputum 144 cultures [20] . Patients who converted sputum cultures to negative before the start of 145 MDR TB treatment were defined as having a 1 day conversion time. A secondary 146 outcome of interest was poor tuberculosis treatment outcome and was defined as a 147 patient who died, interrupted treatment, or had treatment failure.
149
The primary exposures of interest were VDR gene polymorphisms. Participant samples 150 were genotyped using the Affymetrix® Axiom Pan-African Array according to the 151 manufacturer's instructions [21] . Quality checks were performed to ensure the overall 152 SNP call rate was >95% and that there was no sex mismatch between genotypic and 153 phenotypic measurement. SNPs were excluded if they had an unknown chromosomal 154 location, a call rate less than 95%, a Hardy-Weinberg Equilibrium (HWE) p-value less 155 than 0.0001 or a minor allele frequency (MAF) less than 0.05. After quality control filters, Smoking status and alcohol use were self-reported by study patients. Both smoking 165 status and alcohol use were categorized dichotomously as current use (yes/no). Of 121 VDR SNPs examined, 10 were significantly associated (p<0.05) with hazard rate 221 of sputum culture conversion in multivariable analyses ( Table 2 ). The estimated slower 222 conversion rate (adjusted hazard ratio of sputum culture conversion <1.0) ranged from 223 0.30 (95% CI 0.14-0.67) for rs74085240 to 0.64 (95%CI 0.42-0.98) for rs11168287. For 224 example, each additional risk allele on SNP rs74085240 delayed the rate of culture 225 conversion by 70% (aHR 0.55, 95% CI 0.36-0.85). Two VDR SNPs (rs11168327 and 226 rs11574143) were associated with significantly improved rate (adjusted hazard ratio 227 >1.0) of culture conversion (Table 2) .
Overall, 19% (17/88) of patients had a poor TB treatment outcome and 3 additional 230 patients withdrew treatment. We did not detect any genotypes associated with a 231 significant increased odds of poor TB treatment outcome (Table 3) .
233
Discussion 234 We examined 121 SNPs in the VDR gene region and found a subset to be associated 235 with rate of sputum culture conversion among patients with MDR TB in South Africa.
236
Specifically, we identified 9 VDR SNPs that were associated with an estimated 50% to 237 25% reduced (delayed conversion) rate of sputum culture conversion among patients To our knowledge, only one previous study examined the association between VDR 267 genotypes and time to culture conversion in patients with MDR TB. In 2012 Rathored et directly. Second, we did not measure any immune modulating signals. Vitamin D is 299 hypothesized to affect sputum culture conversion through immune modulation of 300 cytokines (interferon-gamma, IL-2, IL-12) chemokines (chemokine ligand (CXCL)-9, 301 CXCL-10, matrix metallopeptidase-9) and antigen stimulated responses (Th1) [23] . 302 Consequently, we were unable to determine if VDR SNPs influenced the expression of 303 immune modulating signals that may affect rate of culture conversion. Third, our sample 304 had relatively low power and we were therefore unable to adjust statistical tests for 305 multiple comparisons. We did not have power to adjust for covariates in the logistic 306 regression models that were used to estimate the odds of poor MDR TB treatment 307 outcome by VDR SNPs. Fourth, we did not examine sputum culture reversions to 308 positive. The analysis only analyzed the association between VDR SNPs and the 309 patients' first sputum culture conversion and therefore does not assess the association 310 with sustained conversion. Acknowledgements 325 We are grateful to the study team at the University of KwaZulu-Natal for their tireless 326 efforts in data collection, record abstraction, participant recruitment and interviews.
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